Search

Search Constraints

You searched for: Author/Creator Jou A. investigator.

Search Results

1. Abacavir usage patterns and hypersensitivity reactions in the EuroSIDA cohort. Issue 4 (22nd December 2017)

2. Discontinuation of dolutegravir, elvitegravir/cobicistat and raltegravir because of toxicity in a prospective cohort2. Issue 3 (27th January 2019)

3. Hepatitis delta infection among persons living with HIV in Europe. (21st January 2023)

4. Incidence of cancer and overall risk of mortality in individuals treated with raltegravir‐based and non‐raltegravir‐based combination antiretroviral therapy regimens. Issue 2 (6th October 2017)

5. Infection‐related and ‐unrelated malignancies, HIV and the aging population. Issue 8 (18th February 2016)

6. The association between hepatitis B virus infection and nonliver malignancies in persons living with HIV: results from the EuroSIDA study. Issue 6 (9th December 2021)